Clinical Trial Update: Study Examining PrEP-001 in Subjects With Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PrEP-001 in subjects with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PrEP-001

Snippet

Sponsor: Hvivo | Conditions: Asthma | Phase 2 | Status: COMPLETED